Peiwen Duan

机构：Shanghai Changzheng Hospital

发表论文 9 篇 · 总被引 109 次 · h-index 6

代表论文

• XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor (2021 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• MYT1 attenuates neuroblastoma cell differentiation by interacting with the LSD1/CoREST complex (2020 · Oncogene · 被引 22)
• Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer (2017 · Oncology Reports · 被引 18)
• P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma (2023 · Molecular & Cellular Proteomics · 被引 16)
• Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification (2024 · British Journal of Cancer · 被引 14)
• 15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1 (2021 · International Journal of Medical Sciences · 被引 8)